Lawrence E. Crane

Array ( [id] => 5485978 [patent_doc_number] => 20090275743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHOD OF PREPARING CARRIER TO SEPARATE NUCLEIC ACIDS, CARRIER AND MICRO CHANNEL TO SEPARATE NUCLEIC ACIDS, AND METHOD AND APPARATUS FOR SEPARATING NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/432078 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8026 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275743.pdf [firstpage_image] =>[orig_patent_app_number] => 12432078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055925 [patent_doc_number] => 20110112285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'NOVEL METHOD FOR PREPARING OLIGONUCLEOTIDES COMPRISING A 5-PHOSPHATE MONOESTER OR 5-THIOPHOSPHATE MONOESTER END' [patent_app_type] => utility [patent_app_number] => 12/988220 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7260 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112285.pdf [firstpage_image] =>[orig_patent_app_number] => 12988220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8808017 [patent_doc_number] => 08445669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Production process of ethynylthymidine compounds from 5-methyluridine as a starting material' [patent_app_type] => utility [patent_app_number] => 12/936789 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21350 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648626 [patent_doc_number] => 08802638 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-08-12 [patent_title] => 'Flavonoid treatment of glycogen synthase kinase-based disease' [patent_app_type] => utility [patent_app_number] => 12/421342 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 54 [patent_no_of_words] => 10704 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12421342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6308230 [patent_doc_number] => 20100069623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Method for preparing oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/417750 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069623.pdf [firstpage_image] =>[orig_patent_app_number] => 12417750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701712 [patent_doc_number] => 08394934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Method and process for synthesis of 2\',3\'-didehydro-2\',3\'-dideoxynucleosides' [patent_app_type] => utility [patent_app_number] => 12/933619 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6688 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039402 [patent_doc_number] => 20110092451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'NUCLEOTIDE ANALOGUES WITH QUATERNARY CARBON STEREOGENIC CENTERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/933291 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18370 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092451.pdf [firstpage_image] =>[orig_patent_app_number] => 12933291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527884 [patent_doc_number] => 20090197961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Diclofenac Formulations and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/399175 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12211 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197961.pdf [firstpage_image] =>[orig_patent_app_number] => 12399175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070054 [patent_doc_number] => 20110044904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'CRYSTAL FORMS OF 2--ADENOSINE' [patent_app_type] => utility [patent_app_number] => 12/918213 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 10970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044904.pdf [firstpage_image] =>[orig_patent_app_number] => 12918213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137501 [patent_doc_number] => 20110009609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => '2\'-HYDROXY-PROTECTED RIBONUCLEOSIDE DERIVATIVE AND PRODUCTION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/919295 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9644 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009609.pdf [firstpage_image] =>[orig_patent_app_number] => 12919295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811330 [patent_doc_number] => 08133861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Systemic purine administration: modulating axonal outgrowth of central nervous system neurons' [patent_app_type] => utility [patent_app_number] => 12/393419 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 12954 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133861.pdf [firstpage_image] =>[orig_patent_app_number] => 12393419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9060122 [patent_doc_number] => 08546557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Methods of making nucleoside tetraphosphate analogs' [patent_app_type] => utility [patent_app_number] => 12/867879 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11124 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993837 [patent_doc_number] => 20110015384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'SULFURIZATION AGENT AND ITS USE' [patent_app_type] => utility [patent_app_number] => 12/866608 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4980 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015384.pdf [firstpage_image] =>[orig_patent_app_number] => 12866608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555679 [patent_doc_number] => 08067580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Isolation of DNA, RNA and protein from a single sample' [patent_app_type] => utility [patent_app_number] => 12/863775 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4157 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067580.pdf [firstpage_image] =>[orig_patent_app_number] => 12863775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266583 [patent_doc_number] => 20100298256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/810147 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12037 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298256.pdf [firstpage_image] =>[orig_patent_app_number] => 12810147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621512 [patent_doc_number] => 20100324279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'CRYSTAL FORMS OF 2-[2-(4-CHLOROPHENYL)ETHOXY]ADENOSINE' [patent_app_type] => utility [patent_app_number] => 12/742768 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17123 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324279.pdf [firstpage_image] =>[orig_patent_app_number] => 12742768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662539 [patent_doc_number] => 08809519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Method for nucleic acids isolation' [patent_app_type] => utility [patent_app_number] => 12/747802 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5034 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330682 [patent_doc_number] => 20090111159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'KITS AND PROCESSES FOR REMOVING CONTAMINANTS FROM NUCLEIC ACIDS IN ENVIRONMENTAL AND BIOLOGICAL SAMPLES' [patent_app_type] => utility [patent_app_number] => 12/326018 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16652 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111159.pdf [firstpage_image] =>[orig_patent_app_number] => 12326018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576071 [patent_doc_number] => 20090143433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'COCKTAIL FOR MODULATION OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/325842 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11838 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143433.pdf [firstpage_image] =>[orig_patent_app_number] => 12325842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275384 [patent_doc_number] => 20100256086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NON-HYDROLYZABLE NUCLEOSIDE DI- OR TRI-PHOSPHATE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/744473 [patent_app_country] => US [patent_app_date] => 2008-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17829 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256086.pdf [firstpage_image] =>[orig_patent_app_number] => 12744473 [rel_patent_id] =>[rel_patent_doc_number] =>)